Sumitomo Chemical India Ltd
Sumitomo Chemical India Q2 Results 2026 (FY27): Capex ₹150 Cr
Q2 FY27 investor presentation: what the company reported on revenue, margins and capex.
Sumitomo Chemical India Ltd Q2 FY27 key numbers
- Revenue
- Q2FY27 revenue from operations reported at Rs. 907 crore, down 2% YoY (Q2FY26 revenue was Rs. 929.8 crore).
As stated in Sumitomo Chemical India Ltd's Q2 FY27 investor presentation · published 27 Oct 2026. Reported figures, not investment advice.
Based on Sumitomo Chemical India Ltd's Q2 FY27 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.
The short version
Q2FY27 revenue from operations reported at Rs. Quarterly EBITDA: Rs.
From Sumitomo Chemical India Ltd's Q2 FY27 earnings-call transcript · updated 27 Oct 2026.
Revenue & Sales Performance
- Q2FY27 revenue from operations reported at Rs. 907 crore, down 2% YoY (Q2FY26 revenue was Rs. 929.8 crore).
- H1FY27 revenue was Rs. 1,971 crore, down 1% YoY from Rs. 1,987 crore in H1FY26.
- Q2FY27 sales volumes declined by a high-single-digit percentage; volume decline partly offset by price increases in March-June 2026.
- Domestic Q2 revenue grew 2% YoY to Rs. 774 crore; exports declined 23% to Rs. 127 crore.
- Margins impacted by absorption of higher-cost inventory purchased in Q1FY27.
2 more points from Sumitomo Chemical India Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
- Quarterly EBITDA: Rs. 186 crore in Q2FY27, down 15% YoY (from Rs. 218 crore in Q2FY26).
- Operating (EBITDA) Margin: 20.5% in Q2FY27, down 297 bps YoY (from 23.4% in Q2FY26).
- Profit After Tax (PAT): Rs. 157 crore in Q2FY27, down 11% YoY (from Rs. 178 crore in Q2FY26).
2 more points from Sumitomo Chemical India Ltd's call on margins
Create a free account to keep reading this call
Capital Expenditure Plans
- Capex Announced January 2026:
- Herbicide intermediate plant at Dahej site
- Strategic investment to develop Dahej as global manufacturing hub
- Using parent company’s process know-how initially
- Followed by future forward/backward integration projects
- Capex budget: ~Rs 150 crore
- Commercialization: Not stated
- Fitment for two additional molecules (1 fungicide, 1 herbicide) at Tarapur site
- For supply to parent company
- Leverages existing infrastructure to enhance asset utilization
- Capex budget: ~Rs 10 crore
- Payback period: <5 years from operations start
- Estimated Commercialization: Q4 FY2027-28
- Capacity Expansion Strategy:
- Invest ~15% of consolidated EBITDA annually for manufacturing upgrade & capacity expansion
- Targeting operational efficiencies, safety, and Responsible Care compliance
- Status:
2 more points from Sumitomo Chemical India Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Fertilizers & Agrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Sumitomo Chemical India Ltd said on fundraising & capital structure — free account, 30 seconds.
Sumitomo Chemical India Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹891 Cr, net profit ₹156 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Sumitomo Chemical India Ltd's management said in earlier quarters
- Q3 FY24 earnings call analysis →
- Q1 FY25 earnings call analysis →
- Q3 FY25 earnings call analysis →
- Q1 FY26 earnings call analysis →
- Q4 FY25 earnings call →
- Q2 FY25 earnings call →
- Q4 FY24 earnings call →
- Q2 FY24 earnings call →
- Q4 FY23 earnings call →
- Q2 FY23 earnings call →
- Q4 FY22 earnings call →
- Q2 FY22 earnings call →
Others in Fertilizers & Agrochemicals this season
- Astec Lifescienc (Q2 FY27)
2.3% YoY decline. Key results statement takeaways from Astec Lifescienc's Q2 FY27 results statement — and how it ranks against sector peers.
- Rallis India (Q2 FY27)
861 Cr. Key investor presentation takeaways from Rallis India's Q2 FY27 investor presentation — and how it ranks against sector peers.
Arthneeti Pro · Annual
Sumitomo Chemical India Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Sumitomo Chemical India Ltd Q2 FY27 results?
Q2FY27 revenue from operations reported at Rs. Quarterly EBITDA: Rs.
What is Sumitomo Chemical India Ltd share price analysis?
Sumitomo Chemical India Ltd currently shows a neutral. The stock trades at a P/E of 30.9 with a market cap of ₹17,665 Cr. Investors should review the full earnings analysis for detailed insights.
Is Sumitomo Chemical India Ltd planning capital expenditure?
Capex Announced January 2026: - Herbicide intermediate plant at Dahej site - Strategic investment to develop Dahej as global manufacturing hub - Using parent company’s process know-how
Keep Sumitomo Chemical India Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.